Product
Pneumococcal Polyvalent Vaccine
Aliases
PCV 23, Pneumococcal 23-valent Polysaccharide Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Vaccine Polyvalent (5 other aliases)
3 clinical trials
5 indications
Indication
Stage I Small Lymphocytic LymphomaIndication
Chronic Lymphocytic LeukemiaIndication
Small Lymphocytic LymphomaClinical trial
Phase II Study of Lenalidomide to Repair Immune Synapse Response and Humoral Immunity in Early-Stage, Asymptomatic Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) With High-Risk Genomic FeaturesStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Phase II Comparative Study of Anti-Pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic LeukemiaStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Phase II Study of the Efficacy of the Pneumococcal Pneumonia Vaccine Series in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency (PROTECT CLL)Status: Recruiting, Estimated PCD: 2025-01-07